CD44 and non-small cell lung carcinoma: The present study is a followup to a survey comparing the expression of several well-known stem/progenitor markers (CD44, CD90, CD117, CD133) on cytokeratin+ cells in NSCL tumors, adjacent grossly normal lung, and NSCLC malignant pleural effusions (MPE) [5].